IQQQ offers high income (15.66% yield) by tracking the Nasdaq 100 with a daily covered call strategy, balancing income and ...

Novo Nordisk (NVO) is a healthcare company that discovers, develops, and markets medical products. The company operates in ...

Both stocks have huge opportunities still in front of them. When it comes to investing, sometimes you want to take a big swing. After all, it's not always the number of winners in your portfolio that ...

European shares made cautious gains on Monday, with Gucci -owner Kering leading the pack following a leadership change. The ...

Nvidia (NVDA, Financials) said Tuesday it is partnering with Novo Nordisk to accelerate drug discovery using its generative ...

Amid the tragedy of the Israel-Iran conflict, stocks are proving stoic. Futures early Monday, as the missile attacks continued, showed the S&P 500 once again reclaiming the 6,000 mark. That's only ...

We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.

Recursion Pharmaceuticals ( RXRX 2.13%) is not the most famous artificial intelligence (AI) stock on the market, but the ...

Novo Nordisk’s annual report contains an interesting footnote on its key drug, Ozempic, which last year accounted for $19 ...

Nvidia (NVDA.O) will build its first artificial intelligence cloud platform for industrial applications in Germany, CEO ...

Novo Nordisk will begin phase 3 trials for amycretin in early 2026 following promising weight loss data and regulatory ...